↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Katz U) "

Search: WFRF:(Katz U)

Result 1-10 of 296

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Aad, G., et al. (author) Drift Time Measurement in the ATLAS Liquid Argon Electromagnetic Calorimeter using Cosmic Muons 2010 In: European Physical Journal C. Particles and Fields. - : Springer Science and Business Media LLC. - 1434-6044 .- 1434-6052. ; 70:3, s. 755-785 Journal article (peer-reviewed)
2.	Aad, G., et al. (author) Readiness of the ATLAS liquid argon calorimeter for LHC collisions 2010 In: European Physical Journal C. Particles and Fields. - : Springer Science and Business Media LLC. - 1434-6044 .- 1434-6052. ; 70:3, s. 723-753 Journal article (peer-reviewed)
3.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
4.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
5.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
7.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
8.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)
9.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)
10.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 296

Refine your search

Type of publication: journal article (288); research review (5); conference paper (2)

Type of content: peer-reviewed (292); other academic/artistic (3)

Author/Editor: Katz, U. (212); Hofmann, W. (155); Becherini, Yvonne (148); Lohse, T. (147); Bulik, T. (145); Fontaine, G. (145); show more...; Khelifi, B. (145); Moulin, E. (145); Egberts, K. (144); Glicenstein, J. F. (144); Kosack, K. (144); Marandon, V. (144); Moderski, R. (144); de Naurois, M. (144); Ohm, S. (144); Ostrowski, M. (144); Rudak, B. (144); Schwanke, U. (144); Aharonian, F. (143); Boisson, C. (143); Lamanna, G. (143); Niemiec, J. (143); Panter, M. (143); Quirrenbach, A. (143); Renaud, M. (143); Rieger, F. (143); Santangelo, A. (143); Fiasson, A. (142); Hinton, J. A. (142); Horns, D. (142); Sol, H. (142); van Eldik, C. (142); Wagner, S. J. (142); Komin, Nu. (141); Marcowith, A. (141); Rowell, G. (141); Sahakian, V. (141); Terrier, R. (141); Gallant, Y. A. (140); Djannati-Atai, A. (139); Katarzynski, K. (139); Pita, S. (139); Steenkamp, R. (139); Hermann, G. (138); Stegmann, C. (138); Venter, C. (137); Vincent, P. (137); Brun, F. (136); Kluzniak, W. (136); Vasileiadis, G. (136); show less...

University: Stockholm University (158); Linnaeus University (148); Uppsala University (103); Lund University (44); Karolinska Institutet (37); Luleå University of Technology (29); show more...; Royal Institute of Technology (24); Chalmers University of Technology (16); University of Gothenburg (12); Umeå University (9); University of Skövde (7); Högskolan Dalarna (3); Linköping University (1); show less...

Language: English (296)

Research subject (UKÄ/SCB): Natural sciences (257); Medical and Health Sciences (24); Engineering and Technology (12); Social Sciences (4); Humanities (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view